Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression

Liver International

Volumn 28, Issue 9, 2008, Pages 1207-1216

  Gressner, Olav A ^a   Lahme, Birgit ^a   Siluschek, Monika ^a   Rehbein, Katharina ^a   Weiskirchen, Ralf ^a   Gressner, Axel M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

(p)Smad2 3; Activin A; Alk4; CTGF; Hepatocytes; Intracrine signalling

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ACTIVIN A; ALKALINE PHOSPHATASE; ALPHA ACTIVIN A ANTIBODY; CARBON TETRACHLORIDE; CONNECTIVE TISSUE GROWTH FACTOR; FOLLISTATIN; INHIBIN A; PROTEIN ANTIBODY; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENE SILENCING; IMMUNOCYTOCHEMISTRY; LIVER CELL; LIVER INJURY; MALE; NONHUMAN; PRIMED IN SITU LABELING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ACTIVINS; ANIMALS; AUTOCRINE COMMUNICATION; CARBON TETRACHLORIDE; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; HEPATITIS, TOXIC; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; MALE; PARACRINE COMMUNICATION; RATS; RATS, SPRAGUE-DAWLEY; SMAD2 PROTEIN; SMAD3 PROTEIN; UP-REGULATION;

EID: 51649091208     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01729.x     Document Type: Article

References (44)

1. Ying S-Y, Zhang Z, Furst B, et al. Activins and activin receptors in cell growth. Proc Soc Exp Biol Med 1997; 214: 114-22.
2. Rodgarkia-Dara C, Vejda S, Erlach N, et al. The activin axis in liver biology and disease. Mutat Res 2006; 613: 123-37.
3. Kogure K, Zhang YQ, Maeshima A, et al. The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology 2000; 31: 916-21.
4. Yasuda H, Mine T, Shibata H, et al. Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993; 92: 1491-6.
5. Ichikawa T, Zhang YQ, Kogure K, et al. Transforming growth factor β and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 2001; 34: 918-25.
6. Hully JR, Chang L, Schwall RH, et al. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 1994; 20: 854-61.
7. Schwall RH, Robbins K, Jardieu P, et al. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 1993; 18: 347-56.
8. Date M, Matsuzaki K, Matsushita M, et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J Hepatol 2000; 32: 251-61.
9. Wada W, Kuwano H, Hasegawa Y, Kojima I. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 2004; 145: 2753-9.
10. Huang X, Li DG, Wang ZR, et al. Expression changes of activin A in the development of hepatic fibrosis. World J Gastroenterol 2001; 7: 37-41.
11. Patella S, Phillips DJ, Tchongue J, et al. Follistatin attenuates early liver fibrosis: Effects on hepatic stellate cell activation and hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol 2006; 290: G137-44.
12. De Bleser P, Niki T, Xu G, et al. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology 1997; 26: 905-12.
13. Sugiyama M, Ichida T, Sato T, et al. Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology 1998; 114: 550-8.
14. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-β in hepatic fibrosis. Front Biosci 2002; 7: D793-D807.
15. Oberhammer F, Bursch W, Parzefall W, et al. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res 1991; 51: 2478-85.
16. Gressner AM, Polzar B, Lahme B, Mannherz HG. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor-beta. Hepatology 1996; 23: 571-81.
17. Oberhammer FA, Pavelka M, Sharma S, et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-beta1. Proc Natl Acad Sci USA 1992; 89: 5408-12.
18. Leask A, Abraham DJ. All in the CCN family: Essential matricellular signaling modulators emerge from the bunker. J Cell Sci 2006; 119: 4803-10.
19. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. Febs Lett 1993; 327: 125-30.
20. Abreu JG, Ketpura N I, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 2002; 4: 599-604.
21. Rachfal AW, Brigstock DR. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003; 26: 1-9.
22. Hayashi N, Kakimuma T, Soma Y, et al. Connective tissue growth factor is directly related to liver fibrosis. Hepato-Gastroenterology 2002; 49: 133-5.
23. George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents n -nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 2007; 14: 790-803.
24. Li G, Xie Q, Shi Y, et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. J Gene Med 2006; 8: 889-900.
25. Gressner O, Lahme B, Demirci I, et al. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol 2007; 47: 699-710.
26. Weng HL, Ciuclan L, Liu Y, et al. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 2007; 46: 1257-70.
27. Gressner OA, Lahme B, Siluschek M, et al. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. J Cell Mol Med 2008; in press.
28. Seglen PO. Preparation of isolated rat liver cells. In: Prescott DM, ed. Methods in Cell Biology. New York: Academic Press, 1987; 29-83.
29. Gressner AM, Pfeiffer T. Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulfate synthesis in hepatocytes. J Clin Chem Clin Biochem 1986; 24: 821-9.
30. Krull N, Zimmermann T, Gressner AM. Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-beta1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat. Hepatology 1993; 18: 581-9.
31. Meyer DH, Krull N, Dreher KL, Gressner AM. Biglycan and decorin gene expression in normal and fibrotic rat liver: Cellular localization and regulatory factors. Hepatology 1992; 16: 204-16.
32. Gao CF, Gressner G, Zoremba M, Gressner AM. Transforming growth factor-beta (TGF-beta) expression in isolated and cultured rat hepatocytes. J Cell Physiol 1996; 167: 394-405.
33. Roth S, Michel K, Gressner AM. (Latent) transforming growth factor-beta in liver parenchymal cells, its injury-dependent release and paracrine effects on hepatic stellate cells. Hepatology 1998; 27: 1003-12.
34. Gressner AM, Wulbrand U. Variation of immunocytochemical expression of transforming growth factor (TGF)-beta hepatocytes in culture and liver slices. Cell Tissue Res 1997; 287: 143-52.
35. Inman GJ, Nicolás FJ, Callahan JF, et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62: 65-74.
36. Roth-Eichhorn S, Kühl K, Gressner AM. Subcellular localization of (latent) transforming growth factor β and the latent TGF-β binding protein in rat hepatocytes and hepatic stellate cells. Hepatology 1998; 28: 1588-96.
37. Tamatani T, Kobayashi H, Tezuka K, et al. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia. Biochem Biophys Res Commun 1998; 251: 748-52.
38. Gressner AM, Yagmur E, Lahme B, et al. Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 2006; 52: 1815-7.
39. Zeisberg M, Yang C, Martino M, et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007; 282: 23337-47.
40. Cheng O, Thuillier R, Sampson E, et al. Connective tissue growth factor is a biomarker and mediator of kidney allograft fibrosis. Am J Transplant 2006; 6: 2292-306.
41. Endo D, Maku-Uchi M, Kojima I. Activin or follistatin: Which is more beneficial to support liver regeneration after massive hepatectomy? Endocr J 2006; 53: 73-8.
42. O'brien TP, Yang GP, Sanders L, Lau LF. Expression of cyr 61, a growth factor-inducible immediate-early gene. Mol Cell Biol 1990; 10: 3569-77.
43. Wahab NA, Weston BS, Roberts T, Mason RM. Connective tissue growth factor and regulation of the mesangial cell cycle: Role in cellular hypertrophy. J Am Soc Nephrol 2002; 13: 2437-45.
44. Cimica V, Batusic D, Haralanova-Ilieva B, et al. Serial analysis of gene expression (SAGE) in rat liver regeneration. Biochem Biophys Res Commun 2007; 360: 545-52.